glycopyrrolate
glycopyrrolate is listed in the FDA National Drug Code directory with 50 NDC codes, marketed under brand names including GLYCOPYRROLATE, Glycopyrrolate, glycopyrrolate. Available dosage forms: injection, tablet, injection, solution, liquid, solution.
Drug details
- Generic Name
- glycopyrrolate
- Brand Names
- GLYCOPYRROLATE, Glycopyrrolate, glycopyrrolate, Cuvposa, GLYRX-PF
- Application Number
- ANDA210927
- Sponsor
- Solco Healthcare US, LLC
- NDC Codes
- 50
- Dosage Forms
- INJECTION, TABLET, INJECTION, SOLUTION, LIQUID, SOLUTION
- Routes
- INTRAMUSCULAR, INTRAVENOUS, ORAL
- Active Ingredients
- GLYCOPYRROLATE
Indications and Usage
1 INDICATIONS AND USAGE Glycopyrrolate Oral Solution is indicated to reduce chronic severe drooling in patients aged 3 to 16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy). Glycopyrrolate Oral Solution is an anticholinergic indicated to reduce chronic severe drooling in patients aged 3-16 years with neurologic conditions associated with problem drooling (e.g., cerebral palsy). (1)